1. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus 
P.-R. Hsueh, L.-M. Huang, P.-J. Chen, C.-L. Kao, P.-C. Yang 
Clinical Microbiology and Infection 
Volume 10, Issue 12, Pages (December 2004)
DOI: /j x
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Chronological evolution of IgG, IgM, and IgA antibodies to SARS-associated coronavirus (SARS-CoV) in 30 patients with SARS. (a) Cumulative proportion against time required for seroconversion to IgG, IgM and IgA according to immunofluorescent antibody (IFA) assays. (b) Cumulative proportion against time required for seroconversion to IgG according to ELISA. (c) Cumulative proportion against time required for peak levels of antibodies according to IFA assays.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Dynamic changes of IgG, IgM, IgA and neutralisation (NT) antibodies against SARS-CoV in two previously healthy patients with SARS. (a) Antibody changes in a SARS patient who received corticosteroid, intravenous immunoglobulin (IVIG) and mechanical ventilation. (b) Antibody changes in a SARS patient who received corticosteroid therapy only.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions